Read more
Fisher & Paykel Healthcare Corporation Limited advises that the strike price for the dividend reinvestment plan (DRP) operating in respect of the dividend payable on Friday 8 July 2011 has been set at NZ$2.6341 per share.
Fisher & Paykel Healthcare Corporation Limited is pleased to offer its ordinary shareholders residing in New Zealand and Australia the option to participate in a Dividend Reinvestment Plan (DRP).
Unique, lightweight and flexible extension tube for stable prong and mask fixation while allowing head movement.
Fisher & Paykel Healthcare Corporation Limited (NZX:FPH, ASX:FPH) advises that the strike price for the dividend reinvestment plan (DRP) operating in respect of the dividend payable...
Fisher & Paykel Healthcare Corporation Limited advises that the strike price for the dividend reinvestment plan operating in respect of the dividend payable on Friday 19 December 2014 has been set at NZ$6.0532 per share.
Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) advises that the strike price for the dividend reinvestment plan (DRP) operating in respect of the dividend payable on Friday 10 July 2015 has been set at NZ$6.9484 per share.
Fisher & Paykel Healthcare Corporation Limited (NZX:FPH, ASX:FPH) advises that the strike price for the dividend reinvestment plan (DRP) operating in respect of the dividend payable on Wednesday 23 December 2015 has been set at NZ$8.4661 per share.
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
The heating and humidifying of respiratory gases is crucial for intubated patients. Learn about humidification devices, including active and passive.
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment
The AIRVO 2 family enables the transition of Optiflow therapy across critical, non-critical areas of the hospital and into the home.
Humidification for patients using a mask at home
Humidification for patients with a tracheostomy at home
Our newest Airvo features an integrated battery, high-pressure oxygen input and a broader flow range.
Optiflow nasal high flow therapy explained, what is it and how does it work?
F&P Solo™ Nasal is the world’s first AutoFit™ mask. It simplifies setup like no other, using AutoLock™ technology - stretch to fit, touch to adjust.
Airvo, F&P 950 and F&P 850 – this trio of humidification and respiratory support devices facilitate multiple respiratory therapies across the hospital
Join our global team. View and apply for jobs with us.
Get in touch with our team, find a distributor or send an enquire.
We value your privacy. Our websites and applications use cookies to function properly and securely.